Amy Tenderich Explains the Value of Patient-Centered Diabetes Care

Amy Tenderich of DiabetesMine.com, a web-based news source for persons with diabetes, took part in panel discussions at Patient-Centered Diabetes Care: Putting Theory into Practice, sponsored by The American Journal of Managed Care.

Related Videos

Related Content

Advertisement

December 26th 2024

The Balance of Managing Younger Patients With MPNs for Long-Term Treatment

Laura Joszt, MA

There are a number of considerations both in the short and long term to consider when making treatment decisions for younger patients with myeloproliferative neoplasms (MPNs).

December 26th 2024

Managed Care Cast Presents: BTK Inhibitors in Treatment-Naive Patients With CLL and MCL

A trio of experts discuss the treatment of chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL) with Bruton tyrosine kinase (BTK) inhibitors, including cost considerations.

December 23rd 2024

Precision Oncology in NSCLC: Overcoming Patient Selection Barriers

Skylar Jeremias

Ryan Nguyen, DO, physician and researcher at the University of Illinois Chicago, emphasizes the transformative impact of immunotherapy in non–small cell lung cancer (NSCLC) and the need for precise biomarkers and equitable access to advanced treatments through systemic testing protocols.

December 23rd 2024

Five Years Later: Ongoing COVID-19 Challenges, Next Steps

Brooke McCormick

On this episode of Managed Care Cast, we speak with Jenny Han, MD, of Emory School of Medicine and Grady Hospital, about COVID-19, long COVID, and strategies for prevention and care.

December 20th 2024

Team-Based CINEMA Program Targets SDOH and Precision Care in Diabetes

Hayden E. Klein

Ian Neeland, MD, discusses the CINEMA program's impact on addressing social determinants of health (SDOH) in Ohio and the importance of precision risk tests to reduce cardiovascular metabolic disease risk.

December 20th 2024

Dr Yehuda Handelsman on How DCRM 2.0 Guidelines Refine CRM Disease Management

Brooke McCormick

In this interview, Yehuda Handelsman, MD, highlights key updates to the Diabetes, Cardiorenal, and Metabolic (DCRM) guidelines in DCRM 2.0, shaped by global collaboration and recent clinical insights.

Related Content

Advertisement

December 26th 2024

The Balance of Managing Younger Patients With MPNs for Long-Term Treatment

Laura Joszt, MA

There are a number of considerations both in the short and long term to consider when making treatment decisions for younger patients with myeloproliferative neoplasms (MPNs).

December 26th 2024

Managed Care Cast Presents: BTK Inhibitors in Treatment-Naive Patients With CLL and MCL

A trio of experts discuss the treatment of chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL) with Bruton tyrosine kinase (BTK) inhibitors, including cost considerations.

December 23rd 2024

Precision Oncology in NSCLC: Overcoming Patient Selection Barriers

Skylar Jeremias

Ryan Nguyen, DO, physician and researcher at the University of Illinois Chicago, emphasizes the transformative impact of immunotherapy in non–small cell lung cancer (NSCLC) and the need for precise biomarkers and equitable access to advanced treatments through systemic testing protocols.

December 23rd 2024

Five Years Later: Ongoing COVID-19 Challenges, Next Steps

Brooke McCormick

On this episode of Managed Care Cast, we speak with Jenny Han, MD, of Emory School of Medicine and Grady Hospital, about COVID-19, long COVID, and strategies for prevention and care.

December 20th 2024

Team-Based CINEMA Program Targets SDOH and Precision Care in Diabetes

Hayden E. Klein

Ian Neeland, MD, discusses the CINEMA program's impact on addressing social determinants of health (SDOH) in Ohio and the importance of precision risk tests to reduce cardiovascular metabolic disease risk.

December 20th 2024

Dr Yehuda Handelsman on How DCRM 2.0 Guidelines Refine CRM Disease Management

Brooke McCormick

In this interview, Yehuda Handelsman, MD, highlights key updates to the Diabetes, Cardiorenal, and Metabolic (DCRM) guidelines in DCRM 2.0, shaped by global collaboration and recent clinical insights.